Zhan_2017_Eur.J.Med.Chem_127_771

Reference

Title : Amaryllidaceae alkaloids with new framework types from Zephyranthes candida as potent acetylcholinesterase inhibitors - Zhan_2017_Eur.J.Med.Chem_127_771
Author(s) : Zhan G , Liu J , Zhou J , Sun B , Aisa HA , Yao G
Ref : Eur Journal of Medicinal Chemistry , 127 :771 , 2017
Abstract :

Three new Amaryllidaceae alkaloids, named zephycandidines I-III (1-3), were isolated from Zephyranthes candida. The structures of 1-3 were elucidated by spectroscopic analyses including HRESIMS, 1H NMR, 13C NMR, DEPT, HSQC, 1H-1H COSY, HMBC, ROESY, and electronic circular dichroism (ECD), as well as ECD calculation. The absolute configuration of 1 was finally established by single crystal X-ray diffraction using Cu Kalpha radiation. Zephycandidines I (1) and III (3) with new framework types represent the first example of 7-phenyl-hexahydroindole and 5,2'-dimethyl-biphenyl-2-ylamine alkaloids, respectively, and their plausible biosynthetic pathway are proposed. Zephycandidine II (2) is the first C3a-phenyl-hexahydroindole type alkaloid isolated from the genus of Zephyranthes. These new alkaloids 1-3 were evaluated for their acetylcholinesterase (AChE) inhibitory activities, and 3 showed potent AChE inhibitory activity with an IC50 value of 8.82 muM, suggesting that the framework of 5,2'-dimethyl-biphenyl-2-ylamine in 3 may be a potential group for the AChE inhibitory activity. The docking studies of 1-3 and galanthamine with AChE revealed that interactions with W286 and Y337 are necessary for the AChE inhibitory activity.

PubMedSearch : Zhan_2017_Eur.J.Med.Chem_127_771
PubMedID: 27823880

Related information

Citations formats

Zhan G, Liu J, Zhou J, Sun B, Aisa HA, Yao G (2017)
Amaryllidaceae alkaloids with new framework types from Zephyranthes candida as potent acetylcholinesterase inhibitors
Eur Journal of Medicinal Chemistry 127 :771

Zhan G, Liu J, Zhou J, Sun B, Aisa HA, Yao G (2017)
Eur Journal of Medicinal Chemistry 127 :771